Comparison

ALIGN TECHNOLOGY INC (ALGN) vs DEXCOM INC (DXCM)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

ALGN

ALIGN TECHNOLOGY INC

Medical Devices

Revenue, FY25: $4.03B
Net income: $410M
Operating cash flow: $593M
Free cash flow: $491M
Net margin: 10.17%
Operating margin: 13.53%
Gross margin: 67.19%

DXCM

DEXCOM INC

Medical Devices

Revenue, FY25: $4.66B
Net income: $836M
Operating cash flow: $1.44B
Free cash flow: $1.08B
Net margin: 17.94%
Operating margin: 19.56%
Gross margin: 60.10%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	ALGN	DXCM
Revenue growth, latest filed year	+0.90%	+15.60%
Piotroski F-score	6 of 8	7 of 8
P/E against its own history	37.50% below	-

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

ALGN

Cybersecurity
Litigation
Tax
Currency moves
Supply chain
Tariffs

And 21 more.

DXCM

FDA approval
Reimbursement
Cybersecurity
Litigation
Product recalls
Debt covenants

And 15 more.

Tracked managers holding both

Joel Greenblatt Gotham Asset Management 0.07% · 0.02%

Updated Sep 14, 2026 · the newer of the two companies' filings